Clinical Development. PARI shall use Commercially Reasonable Efforts to manufacture and supply the Device, Handsets, and Accessories to Genoa, its Affiliates, or its Permitted Sublicensees for use during clinical trials of the Drug Product(s) by, or on behalf of, Genoa for a price not to exceed: (i) [***] per Handset; (ii) [***] per Device; and (iii) [***] per controller kit (consisting of a control unit and all Accessories required to operate the Device including external hardware required for the data transmission but excluding the Nebulizer Handset) if configured with a display and patient monitoring capabilities, plus additional fees for the wireless communication and the set-up which are needed to send data electronically from the Device for patient monitoring purposes, in each case excluding any taxes, shipping and storage costs associated with such Device. The above mentioned prices may be increased as additional features and Improvements may be implemented as mutually agreed to by the Parties. PARI shall use Commercially Reasonable Efforts to provide [***] of Genoa’s, its Affiliates’, or its Permitted Sublicensees’ requirements for such clinical trials. Genoa shall submit rolling [***] forecasts of its anticipated requirements of Devices and Handsets for the next [***].
Appears in 3 contracts
Sources: License Agreement (Avalyn Pharma Inc.), License Agreement (Avalyn Pharma Inc.), License Agreement (Avalyn Pharma Inc.)